我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

下肢动脉闭塞症性疾病诊治策略的演变与时代意义(PDF)

《中国普外基础与临床杂志》[ISSN:1007-9424/CN:51-1505/R]

期数:
2010年07期
页码:
641-644
栏目:
述评
出版日期:
2010-07-22

文章信息/Info

Title:
 Evolution of Diagnosis and Treatment of Peripheral Arterial Occlusive Diseases and Its Significance
稿件编号:
201007001
作者:
蒋米尔; 黄英
上海交通大学医学院附属第九人民医院血管外科、上海交通大学医学院血管病诊治中心、上海交通大学医学院创伤医学研究所（血管外科）（上海 200011）
Author(s):
-
关键词:
 ; 周围动脉闭塞性疾病;  动脉硬化闭塞症;  血栓闭塞性脉管炎;  动脉血栓形成;  治疗
Keywords:
-
分类号:
R654.4
DOI:
-
文献标识码:
C
摘要:
Abstract:

参考文献/References

 ［1］Surowiec SM, Davies MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery ［J］. J Vasc Surg, 2005; 41(2): 269278.
［2］Conte MS, Bandyk DF, Clowes AW, et al. Results of PREVENT Ⅲ: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery ［J］. J Vasc Surg, 2006; 43(4): 742751.
［3］Jiang ME, Huang Y, Lu M, et al. Revascularization of severely ischemic limbs by staged arteriovenous reversal ［J］. Jpn J Cardiovasc Surg, 1999; 28(4): 215220.
［4］Owens CD, Ho KJ, Conte MS. Lower extremity vein graft failure: a translational approach ［J］. Vasc Med, 2008; 13(1): 6374.
［5］Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application ［J］. Circulation, 1964; 30: 654670.
［6］Wildgruber MG, Berger HJ. Cryoplasty for the prevention of arterial restenosis ［J］. Cardiovasc Intervent Radiol, 2008; 31(6): 10501058.
［7］Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylenecovered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease ［J］. J Vasc Interv Radiol, 2008; 19(6): 823832.
［8］Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection ［J］. Cardiovasc Intervent Radiol, 1990; 13(6): 357363.
［9］DeRubertis BG, Pierce M, Chaer RA, et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infrainguinal intervention ［J］. J Vasc Surg, 2007; 46(4): 709716.
［10］Mannava K, Money SR. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions ［J］. Am J Cardiovasc Drugs, 2007; 7(1): 5966.
［11］Dagher NN, Modrall JG. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins ［J］. Semin Vasc Surg, 2007; 20(1): 1014.
［12］TateishiYuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bonemarrow cells: a pilot study and a randomised controlled trial ［J］. Lancet, 2002; 360(9331): 427435.
［13］Kalka C, Baumgartner I. Gene and stem cell therapy in peripheral arterial occlusive disease ［J］. Vasc Med, 2008; 13(2): 157172.
［14］van Weel V, van Tongeren RB, van Hinsbergh VW, et al. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation ［J］. Ann Vasc Surg, 2008; 22(4): 582597.
［15］蒋米尔, 黄英. 下肢动脉粥样硬化闭塞症治疗的过去、现在和将来 ［J］. 外科理论与实践, 2009; 14(3): 249256.

备注/Memo

备注/Memo:
 【通讯作者】蒋米尔，E-mail: jiangme2005@yahoo.com.cn
【作者简介】蒋米尔（1953年-），男，上海市奉贤县人，硕士研究生，主任医师，博士研究生导师，主研方向为血管疾病的诊断与治疗。
更新日期/Last Update: 2010-07-23